Condensation of sodium 3-oxo-3-(1-phenyl-1H-pyrazol-4-yl)prop-1-en-1-olate (2) with several heterocyclic amines, cyanoacetamide, cyanothioacetamide, and 2-cyanoacetohydrazide gives pyrazolo [1,5-a] 
Introduction
Several pyrazole derivatives received great attention due to their biological and pharmacological activities not only as potential inhibitors of HIV-1 [1] , pesticides [2] , fungicides [3] , antihypertensive agents [4] , and anticancer activity [5] , but also as important and useful starting materials for the synthesis of other fused heterocyclic systems. Furthermore, compounds containing the pyrimidine nucleus are of significant biological importance and are used as antibacterial [6] [7] [8] [9] , antifungal [10, 11] , antitumour [12, 13] , antiviral [13] [14] [15] [16] [17] , anti-inflammatory [18, 19] , and antihypertensive [20] [21] [22] agents. In this work, we synthesized some new pyrazolo [1,5-a] pyrimidine, triazolo [4,3-a] pyrimidine, and thieno [2,3-b] pyridine derivatives.
Experimental
Melting points were measured on Electrothermal IA 9000 series digital melting point apparatus and are uncorrected.
The IR spectra were recorded in potassium bromide discs on a Pye Unicam SP 3300 and Shimadzu FT IR 8101 PC infrared spectrophotometer.
1 H NMR and 13 C NMR spectra were recorded in DMSO-6 using a Varian Gemini 300 NMR spectrometer (300 MHz for 1 H NMR and 75 MHz for 13 C NMR). Mass spectra were recorded on a Shimadzu GCMS-QP1000 EX mass spectrometer at 70 eV. Elemental analysis was carried out at the Microanalytical Centre of Cairo University, Giza, Egypt. All reactions were followed by TLC (Silica gel, Merck). 1-(5-Methyl-1-phenyl-1H-pyrazol-4-yl)ethanone [23] was prepared as reported in the literature. (2) . A mixture of (0.01 mol) 1-(5-methyl-1-phenyl-1H-pyrazol-4-yl)ethanone 1 (2.0 g, 10 mmol) and ethyl formate (0.74 g, 10 mmol) was dropped over a solution of sodium methoxide (0.54 g, 10 mmol) in 20 mL dry ether with stirring. The formed solid product was collected and used directly in the following reactions.
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Synthesis of 5a-d and 9-14.
Method A (general procedure). A mixture of sodium 3-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-3-oxoprop-1-en-1-olate (2) (2.5 g, 10 mmol) and the appropriate 3-amino-5-methylpyrazole 3a, 3-amino-5-phenylpyrazole 3b, 3-amino-4-cyanopyrazole 3c, 3-amino-4-methyl-5-phenylpyrazole 3d, 4,6-dimethyl-2H-pyrazolo [3,4-b] pyridin-3-amine, 2-aminobenzimidazole, 4H-1,2,4-triazol-3-amine, cyanoacetamide, cyanothioacetamide, and 2-cyanoacetohydrazide (10 mmol) and few drops of acetic acid was grinded for 10-20 min (monitored by TLC). The solid products collected by filtration and recrystallized from the suitable solvent gave the respective products 5a-d and 9-14 in an excellent yield.
Method B (general procedure).
A solution of sodium 3-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-3-oxoprop-1-en-1-olate (2) (2.5 g, 10 mmol), the appropriate 3-amino-5-methylpyrazole 3a, 3-amino-5-phenylpyrazole 3b, 3-amino-4-cyanopyrazole 3c, 3-amino-4-methyl-5-phenylpyrazole 3d, 4,6-dimethyl-2H-pyrazolo [3,4-b] pyridin-3-amine, 2-aminobenzimidazole, 4H-1,2,4-triazol-3-amine, cyanoacetamide, cyanothioacetamide, 2-cyanoacetohydrazide (10 mmol), and piperidine acetate (1 mL) in water (3 mL) was refluxed for 10 min. After completion of the reaction, the hot reaction mixture was neutralized with acetic acid (1.5 mL) and then cooled and the solid products collected by filtration and recrystallized from the suitable solvent gave products 5a-d and 9-14 in a good yield, which were identical in all aspects (m.p., mixed m.p., and spectra) with those obtained from Method A. [1,5-a] 
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6-(5-Methyl-1-phenyl-1H-pyrazol-4-yl)-2-oxo-1,2-dihydropyridine-3-carbonitrile (12
6-(5-Methyl-1-phenyl-1H-pyrazol-4-yl)-2-thioxo-1,2-dihydropyridine-3-carbonitrile (13
3-Amino-2-substituted-6-(5-methyl-1-phenyl-1H-pyrazol-4-yl)thieno[2,3-b]-pyridine Derivatives (15-18).
Method A. A mixture of 13 (0.29 g, 1 mmol) and the appropriate ethyl chloroacetate, chloroacetone, -bromoacetophenone or chloroacetonitrile (1 mmol), and 3-5 drops of acetic acid was grinded for 15 min. The resulting solid was collected and recrystallized from ethanol to give the respective compounds, 15-18, in excellent yields. [2,3-b] Methyl-1-phenyl-1H-pyrazol-4-yl)-2H-pyrazolo [3,4-b] pyridin-3-amine (19) . To a solution of the thione 13 (0.29 g, 0.01 mol) in ethanol (10 mL) hydrazine hydrate was added (1 mL) and the mixture was heated under reflux for 12 h. The solution was poured over ice-water mixture and then neutralized by HCl. The solid product was filtered off, dried, and recrystallized from ethanol to afford compound 15. [2 ,3 :3,4] pyrazolo [1,5-a] pyrimidine (20) . To a solution of 19 (1.45 g, 5 mmol) and acetylacetone (0.5 g, 5 mmol), in acetic acid (20 mL) was refluxed for 10 min. The solid product was collected by filtration and recrystallized from acetic acid to afford compound 20. Yield 72%; 
Method B.
A mixture of 13 (0.29 g, 1 mmol) and potassium hydroxide (0. 0.056 g, 1 mmol) in N,N-dimethylformamide (10 mL) was stirred for 2 h at room temperature. The appropriate ethyl chloroacetate, chloroacetone, -bromoacetophenone, or chloroacetonitrile (1 mmol each) was added and stirring was continued for 2 h. The resulting solid was collected and recrystallized from ethanol to give 15-18, respectively.
Ethyl 3-Amino-6-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-thieno
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6-(5-
2,4-Dimethyl-8-(5-methyl-1-phenyl-1H-pyrazol-4-yl)pyrido
Results and Discussion
The starting sodium 3-(5-methyl-1-phenyl-1H-pyrazol-4-yl)-3-oxoprop-1-en-1-olate (2) was prepared via reaction of 1-(5-methyl-1-phenyl-1H-pyrazol-4-yl)ethanone [23] (1) with ethyl formate in the presence of sodium methoxide. Thus, condensation of 2 with 5-amino-3-methylpyrazole (3a) in acetic acid containing piperidine acetate or grinding afforded one isolable product formulated as 2-methyl-7-(5-methyl-1-phenyl-1H-pyrazol-4-yl)pyrazolo [1,5-a] pyrimidine (5a) in good yield (Scheme 1).
1 H NMR for the product revealed the . The reaction seemed to be via the initial nucleophilic attack by the exocyclic amino group at the formyl group, which formed in situ from 1 with water, followed by cyclization and elimination of one molecule of water leading to the formation of the product 5a (Scheme 1). The suggestion of the formation of the alternative isomeric product 7a is based on the initial attack of endocyclic amino group at the formyl group for the formation of 7a. As the spectroscopic data above does not allow one to distinguish between possible products 5a and 7a. The latter suggestion is excluded due to the higher nucleophilicity of the exocyclic primary amino group than the endocyclic amino group. Thus, the mechanism proposed in Scheme 1 seems to be acceptable. In order to establish unambiguously the structure of the product, the crystal structure of a similar previous work has been reported [26] [27] [28] [29] . Also, product was obtained by an alternative synthesis route by reaction of 3-(dimethylamino)-1-(5-methyl-1-phenyl-1H-pyrazol-4-yl)prop-2-en-1-one (8) [25] with 3a. Analogously, condensation of 3b-d with 2 gave corresponding 7-substituted pyrazolo [1,5- 
Conclusion
In summary, we have developed a simple, efficient procedure for the synthesis of pyrazolo [1,5- 
